1. Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury 
Ayako Suzuki, Nancy Yuen, John Walsh, Julie Papay, Christine M. Hunt, Anna Mae Diehl 
Clinical Gastroenterology and Hepatology 
Volume 7, Issue 8, Pages (August 2009)
DOI: /j.cgh
Copyright © 2009 AGA Institute Terms and Conditions

2. Figure 1
An algorithm to define the study population of APAP-associated liver injury. Within the Adverse Event Reporting System database, study population was defined following the algorism. The 6386 cases of APAP-associated liver injury served as the study population. The study population was further classified into serious and nonserious adverse events using the FDA serious adverse event classification. Among serious adverse events, fatal cases were defined by combining the “died” and “life-threatening” classifications.
Clinical Gastroenterology and Hepatology 2009 7, DOI: ( /j.cgh )
Copyright © 2009 AGA Institute Terms and Conditions